Movement Disorders Clinical Trials

Find Movement Disorders Clinical Trials Near You

The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study tests whether a smart shoe (NUSHU) that provides vibrotactile stimulation can improve walking speed in people with Parkinson's disease. Sixteen participants complete two short walking tests-with and without vibration-to compare gait speed, cadence, stride length, usability, and safety. It is a low-risk pilot study meant to generate first evidence for future research.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• A medically confirmed diagnosis of Parkinson's disease on the physiotherapy prescription.

• Stable medication for at least four weeks (no change in dopaminergic therapy).

• The ability to walk at least 200 metres without stopping.

• Minimum age: 18 years

• Sufficient knowledge of German to understand the study information and complete the questionnaires.

• Written informed consent form

Locations
Other Locations
Switzerland
Magnes AG
RECRUITING
Zurich
Contact Information
Primary
Romina Willi
research@magnes.ch
+41442234873
Time Frame
Start Date: 2026-01-10
Estimated Completion Date: 2026-05
Participants
Target number of participants: 16
Treatments
Active_comparator: Vibrotactile feedback while walking
Related Therapeutic Areas
Sponsors
Leads: Magnes AG

This content was sourced from clinicaltrials.gov